[Clinical efficacy and safety of long-term immunomodulating therapy with interferon beta]

Zh Nevrol Psikhiatr Im S S Korsakova. 2008;108(4):24-6.
[Article in Russian]
No abstract available

Publication types

  • Review

MeSH terms

  • Adjuvants, Immunologic / administration & dosage
  • Adjuvants, Immunologic / therapeutic use*
  • Dose-Response Relationship, Drug
  • Follow-Up Studies
  • Humans
  • Injections, Intramuscular
  • Interferon beta-1a
  • Interferon beta-1b
  • Interferon-beta / administration & dosage
  • Interferon-beta / therapeutic use*
  • Multiple Sclerosis / drug therapy*
  • Randomized Controlled Trials as Topic
  • Recombinant Proteins
  • Remission Induction / methods
  • Secondary Prevention
  • Time Factors
  • Treatment Outcome

Substances

  • Adjuvants, Immunologic
  • Recombinant Proteins
  • Interferon beta-1b
  • Interferon-beta
  • Interferon beta-1a